Azitra is trading 12.38% up now at $0.18 after investors continued reacting on August 26, 2026, to the company’s August 21 announcement that NYSE American confirmed restoration of compliance with all continued-listing standards.
- The exchange will remove Azitra’s below-compliance indicator and noncompliant-issuer listing after minimum stockholders’ equity deficiencies were resolved.
- Biotech strength is providing additional support, but the company-specific compliance catalyst is the primary driver.